Criptococosis meníngea en personas que viven con VIH
Serie de casos en un hospital regional argentino
DOI:
https://doi.org/10.14409/sigme.2023.1.e0006Keywords:
Cryptococcus, Opportunistic infections related to AIDS, Meningeal cryptococcosis, criptococosisAbstract
Meningeal cryptococcosis is an opportunistic infection that affects people with human immunodeficiency virus (PLHIV) with a high level of immunosuppression. It is associated with high morbidity and mortality. Due to the lack of official epidemiological data in Argentina and a limited number of published regional studies, the present paper aims to describe the main clinical-biochemical characteristics, therapeutic management and evolution of a group of PLHIV with meningeal cryptococcosis in a referral hospital of the north-central region of the province of Santa Fe (Argentina). 10 patients were included, aged 44 (61-34) years and a mean of 3 (30-0) years of evolution of the HIV infection. When making the first consultation, they presented 15 (40-2) days of evolution, being fever the most common symptom. All of them received treatment with liposomal amphotericin B for 26.5 (44-2) days. Cerebrospinal fluid (CSF) culture control 14 days after starting therapy was positive in 5 individuals. Five subjects evolved favorably with hospital discharge and outpatient follow-up, while five required attention in the Intensive Care Unit for mechanical respiratory assistance. Five of the PLHIV included died.
References
Arechavala, A., Negroni, R., Messina, F., Romero, M., Marín, E., Depardo, R., Walker, L., Y Santiso, G. (2018). Cryptococcosis in an Infectious Diseases Hospital of Buenos Aires, Argentina. Revision of 2041 cases: Diagnosis, clinical features and therapeutics. Revista Iberoamericana de Micologia, 35(1), 1–10. https://doi.org/10.1016/j.riam.2017.04.003.
Bassetti, M., Azoulay, E., Kullberg, B. J., Ruhnke, M., Shoham, S., Vazquez, J., Giacobbe, D. R., Y Calandra, T. (2021). EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 72(Suppl 2), S121–S127. https://doi.org/10.1093/cid/ciaa1751.
Donnelly, J. P., Chen, S. C., Kauffman, C. A., Steinbach, W. J., Baddley, J. W., Verweij, P. E., Clancy, C. J., Wingard, J. R., Lockhart, S. R., Groll, A. H., Sorrell, T. C., Bassetti, M., Akan, H., Alexander, B. D., Andes, D., Azoulay, E., Bialek, R., Bradsher, R. W., Bretagne, S., Calandra, T., … Pappas, P. G. (2020). Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 71(6), 1367–1376. https://doi.org/10.1093/cid/ciz1008
Jarvis, J. N., y Harrison, T. S. (2007). HIV-associated cryptococcal meningitis. AIDS, 21(16), 2119–2129. https://doi.org/10.1097/QAD.0b013e3282a4a64d.
Kambugu, A., Meya, D. B., Rhein, J., O'Brien, M., Janoff, E. N., Ronald, A. R., Kamya, M. R., Mayanja-Kizza, H., Sande, M. A., Bohjanen, P. R., & Boulware, D. R. (2008). Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 46(11), 1694–1701. https://doi.org/10.1086/587667.
Li, Y., Huang, X., Qin, Y., Wu, H., Yan, X. y Chen, Y. (2020). ¿Cuál es el régimen de inducción más adecuado para el tratamiento de la meningitis criptocócica asociada al VIH cuando no se dispone del régimen recomendado? Evidencia de un metanálisis en red. Fronteras en farmacología, 11, 963.
McKenney, J., Bauman, S., Neary, B., Detels, R., French, A., Margolick, J., Doherty, B., & Klausner, J. D. (2015). Prevalence, correlates, and outcomes of cryptococcal antigen positivity among patients with AIDS, United States, 1986-2012. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 60(6), 959–965. https://doi.org/10.1093/cid/ciu937.
Molloy, S. F., Kanyama, C., Heyderman, R. S., Loyse, A., Kouanfack, C., Chanda, D., Mfinanga, S., Temfack, E., Lakhi, S., Lesikari, S., Chan, A. K., Stone, N., Kalata, N., Karunaharan, N., Gaskell, K., Peirse, M., Ellis, J., Chawinga, C., Lontsi, S., Ndong, J. G., … ACTA Trial Study Team (2018). Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa. The New England journal of medicine, 378(11), 1004–1017. https://doi.org/10.1056/NEJMoa1710922.
Mónaco, L. S. y Tamayo Antabak, N. (2008). Criptococosis en pacientes con SIDA: estudio de casos en el Hospital Paroissien en el período 1996-2007. Revista Argentina de Microbiología, 40(4), 218-221.
Mouras, R. y Rueda H. J. (2016). Sociedad Argentina de Infectología. Recomendaciones sobre el manejo en infecciones oportunistas en pacientes con infección por HIV. Criptococosis diseminada. Comisión HIV y ETS. S.A.D.I. 168 pp.
Okongo, M., Morgan, D., Mayanja, B., Ross, A. y Whitworth, J. (1998). Causes of death in a rural, population-based human immunodeficiency virus type 1 (HIV-1) natural history cohort in Uganda. International Journal of Epidemiology, 27(4), 698–702. https://doi.org/10.1093/ije/27.4.698.
Pasquier, E., Kunda, J., De Beaudrap, P., Loyse, A., Temfack, E., Molloy, S. F., Harrison, T. S. y Lortholary, O. (2018). Long-term Mortality and Disability in Cryptococcal Meningitis: A Systematic Literature Review. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 66(7), 1122–1132. https://doi.org/10.1093/cid/cix870.
Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M. H., Pappas, P. G., Powderly, W. G., Singh, N., Sobel, J. D. y Sorrell, T. C. (2010). Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 50(3), 291–322. https://doi.org/10.1086/649858
Rajasingham, R., Smith, R. M., Park, B. J., Jarvis, J. N., Govender, N. P., Chiller, T. M., Denning, D. W., Loyse, A. y Boulware, D. R. (2017). Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. The Lancet. Infectious diseases, 17(8), 873–881. https://doi.org/10.1016/S1473-3099(17)30243-8.
Van der Horst, C. M., Saag, M. S., Cloud, G. A., Hamill, R. J., Graybill, J. R., Sobel, J. D., Johnson, P. C., Tuazon, C. U., Kerkering, T., Moskovitz, B. L., Powderly, W. G., y Dismukes, W. E. (1997). Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. The New England journal of medicine, 337(1), 15–21. https://doi.org/10.1056/NEJM199707033370103
Williamson PR, Jarvis JN, Panackal AA, Fisher MC, Molloy SF, Loyse A y Harrison TS. (2016). Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nature Reviews Neurology. 13(1):13-24. doi: 10.1038/nrneurol.2016.167. Epub 2016
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Melina Beloso, Joaquín Ignacio Coduri Anthonioz Blanc, Agust´ín Martínez, María José Sadonio, Maximiliano Gabriel Castro
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
